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Wnt-signaling enhances neural crest
migration of melanoma cells and induces
an invasive phenotype
Tobias Sinnberg1* , Mitchell P. Levesque2, Jelena Krochmann1, Phil F. Cheng2, Kristian Ikenberg3,
Francisco Meraz-Torres1, Heike Niessner1, Claus Garbe1 and Christian Busch1,4*
Abstract
Background: During embryonic development Wnt family members and bone morphogenetic proteins (BMPs)
cooperatively induce epithelial-mesenchymal transition (EMT) in the neural crest. Wnt and BMPs are reactivated during
malignant transformation in melanoma. We previously demonstrated that the BMP-antagonist noggin blocked
the EMT phenotype of melanoma cells in the neural crest and malignant invasion of melanoma cells in the chick
embryo; vice-versa, malignant invasion was induced in human melanocytes in vivo by pre-treatment with BMP-2.
Results: Although there are conflicting results in the literature about the role of β-catenin for invasion of melanoma
cells, we found Wnt/β-catenin signaling to be analogously important for the EMT-like phenotype of human metastatic
melanoma cells in the neural crest and during invasion: β-catenin was frequently expressed at the invasive front of
human primary melanomas and Wnt3a expression was inversely correlated with survival of melanoma patients.
Accordingly, cytoplasmic β-catenin levels were increased during invasion of melanoma cells in the
rhombencephalon of the chick embryo. Fibroblast derived Wnt3a reduced melanoma cell adhesion and
enhanced migration, while the β-catenin inhibitor PKF115–584 increased adhesion and reduced migration in vitro
and in the chick embryonic neural crest environment in vivo. Similarly, knockdown of β-catenin impaired intradermal
melanoma cell invasion and PKF115–584 efficiently reduced liver metastasis in a chick chorioallantoic membrane
model. Our observations were accompanied by specific alterations in gene expression which are linked to overall
survival of melanoma patients.
Conclusion: We present a novel role for Wnt-signaling in neural crest like melanoma cell invasion and metastasis,
stressing the crucial role of embryonic EMT-inducing neural crest signaling for the spreading of malignant melanoma.
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Background
Melanocytes are derived from the embryonic neural crest.
During and after closure of the neural tube in the trunk of
the embryo, the neural crest is induced by an intricate
crosstalk between bone morphogenetic proteins (BMPs)
and Wnt-signaling [1–4], which could be reproduced in
human induced pluripotent stem cells in vitro [5]. In the
course of this process, neural crest cells undergo
morphological changes accompanied by an altered adhe-
sion and migration capacity. A corresponding morpho-
logical transformation of chick embryonic lens epithelial
cells was designated as epithelial-mesenchymal transition
(EMT) [6]. After induction, neural crest cells migrate
along their designated medial and lateral pathways. Neural
crest cells following the medial pathway form spinal gan-
glia and the autonomic ganglia of the sympathetic chain.
The neural crest-derived progenitors of melanocytes (me-
lanoblasts) migrate along the lateral pathway and colonize
the epidermis [7]. During invasion of the epidermal/der-
mal layer of the skin melanoma cells (arising from mela-
noblasts or melanocytes in the epidermis) morphologically
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pass through an EMT-like program and thus recapitulate
their former neural crest cell specific migratory capacities.
In previous experiments, we observed that human
SKMEL28 [8, 9] and mouse B16-F1 melanoma cells [10]
spontaneously integrate into the neural crest and resume
a physiological neural crest cell migration after trans-
plantation into the neural tube of the chick embryo.
In contrast to melanoma cells, neurospheres generated
from adult mouse subventricular zone (SVZ) stem cells
integrate into the neural crest and perform neural crest
cell migration only after pre-treatment with bone
morphogenetic protein-2 (BMP-2) [11]. BMPs are cons-
titutively expressed in melanoma cells [12]. In line, we
showed that physiological neural crest migration (after
transplantation into the neural tube) and invasive growth
(after transplantation into the optic cup of the chick
embryo) of melanoma cells can be ablated by the BMP-
antagonist noggin [13, 14] and that vice-versa malignant
invasion can be induced by pre-treatment with BMP-2 in
non-transformed human melanocytes [15] clearly demon-
strating that embryonic neural crest signaling pathways
play important roles in the invasive growth of melanoma
cells in vivo.
In a second approach, we demonstrated that the
embryonic transcription factor β-catenin is frequently
activated during melanomagenesis via non-mutational
alterations like reduced expression levels of casein kinase
1α resulting in protein stabilization of the central
Wnt-signaling player β-catenin [16]. Furthermore, we
showed in vitro a pro-migratory and pro-invasive func-
tion of β-catenin in melanoma cells implanted into
human organotypic skin reconstructs [17] which seems
context dependent due to controversial reports in the
literature. In line with a pro-invasive function of neural
crest signaling pathways, it was reported that leflunomide,
an inhibitor of dihydroorotate dehydrogenase, leads to
an abrogation of neural crest development in zebrafish
and decreases melanoma growth in vitro and in mice.
Leflunomide exerts these effects by an inhibition of
neural crest development [18], also suggesting a close
connection between developmental pathways and mel-
anomagenesis. Leflunomide is an agonist of the
ligand-activated transcription factor aryl hydrocarbon
receptor (AhR) and activation by leflunomide leads to
a dysregulation of Wnt signaling not least because its
function as ligand-dependent E3 ubiquitin ligase in
the β-catenin degradation pathway [19–21]. This was
shown to have a tumor suppressing function in intestinal
cancer [22]. However, the peculiarity of the canonical
Wnt-signaling in the context of melanoma has produced
conflicting theses about the correlation of the expression
levels of β-catenin and the progression of the disease
[23, 24], which shows that the role of β-catenin in
melanoma metastasis remains largely unclear. This was
nicely summarized by Weeraratna et al. [25]. Some studies
indicated that β-catenin suppresses invasion of melanoma
cells and that loss of β-catenin predicts a poor survival
rate in melanoma patients [26–29]. Other studies showed
that increased abundance or stabilization of β-catenin
leads to increased melanoma metastasis, both in vitro and
in vivo [30–34]. However, Wnt ligands do play a role in
melanoma cell invasion. Consequently, Wnt5a promoted
melanoma cell invasion and polarized protein localization
by depalmitoylation of the melanoma cell adhesion
molecule (MCAM) at cysteine 590 [35]. Interestingly,
Wnt5a does not exlusively mediate its effects on melan-
oma cells via a non-canonical, protein kinase C (PKC)
dependent Wnt signaling pathway [36, 37], but also
stimulates β-catenin transcriptional activity during
Wnt5a-mediated melanoma invasion and metastasis
[33]. Lastly, it was demonstrated that in addition to
driving melanomagenesis and invasion of melanoma
cells, intrinsic β-catenin signaling prevents anti-tumor
immunity, leading to T-cell exclusion and resistance to
anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy in
melanoma mouse models [38], which could have great
clinical significance.
Going back to embryologic neural crest induction,
we asked in this project whether the Wnt3a/β-catenin
signaling pathway was also directly involved in melan-
oma cell adhesion/migration in vitro and in vivo in
an embryonic micro-environment of the neural crest.
To this end we used in vivo chick embyo models in-
cluding the experimental growth of melanoma brain
[15, 39, 40] and liver metastasis [41, 42] along with
in vitro models.
Methods
Cell lines, cell culture, and generation of
Wnt3a-conditioned medium
The following human metastatic melanoma cell lines
were used in this study: SKMEL28, A375, BLM,
SKMEL19 and. 451Lu. Melanoma cells were cultivated
in HEPES-buffered, 2 mM L-Glutamin containing
RPMI1640-medium (Gibco/ Life Technologies, Darm-
stadt, Germany), which was supplemented with 10%
fetal calf serum (Biochrom, Berlin, Germany) and
100 U ml− 1 Pen-Strep (Gibco/ Life Technologies,
Darmstadt, Germany). All cultures were maintained at
37 °C in a 95% air / 5% CO2 atmosphere at 85%
humidity. For generation of Wnt3a-conditioned
medium (Wnt3a-CM), NIH3T3 murine fibroblasts
constitutively over-expressing Wnt3a (kindly gifted by
Prof. Michael Schwarz, Institute of Toxicology, University of
Tuebingen, Germany) were cultured in DMEM-medium
(Life Technologies, Darmstadt, Germany) supplemented
with 1% FCS for 48 h. NIH3T3 conditioned medium
(3T3-CM) served as control.
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Transcriptome analysis of SKMEL28 melanoma cells and
of zebrafish embryo neural crest
mRNA expression analyses were performed in triplicates
with SKMEL28 melanoma cells (3 experimental groups:
untreated, Wnt3a pre-conditioned for 24 h, or 0.5 μM
PKF115–584 (gifted by Novartis Oncology; Novartis
Institutes for Biomedical Research, Cambridge, MA)
pre-conditioned for 24 h) as described elsewhere [43, 44].
siRNA transfections and lentiviral shRNA
Twenty nanometer siRNA was transfected into
SKMEL28 melanoma cells using the riboxx-FECT
(riboxx Life Sciences) reagent as recommended by
the manufacturer. Briefly, 3 × 105 melanoma cells
were seeded per 6 well cavity, and the next day cells
were transfected using combined Opti-MEM:siRNA
and Opti-MEM:riboxx-FECT (12 μl per cavity) mix-
tures. The incubation time before addition to the
cells was 15 min and the final volume was 2 ml.
Cells were further incubated for 24 h before the
usage in cellular assays. Lentiviral particles were gen-
erated and used as previously described for the
shRNA mediated knockdown of β-catenin in melan-
oma cell lines [17].
Scratch assay
5 × 105 melanoma cells were seeded into 6well plates
and grown until confluency followed by overnight serum
starvation. Six hours before scratching the medium was
exchanged with either a 1:1 mixture of Wnt3a-CM, 3T3-
CM, or normal culture medium containing 0.5 μM
PKF115–584 (Novartis Institutes for Biomedical Research,
Cambridge, MA). Then a scratch was applied using a
200 μl standard pipette tip (Greiner Bio-One International,
order No. 739290, Germany) and detached cells were
removed by exchanging the medium once again with the
corresponding treatment medium. Microphotographs
were taken at 0, 12 and / or 24 h post scratching to
measure the closed area using ImageJ (V 1.50b, NIH,
USA). At least three biological replicates were mea-
sured in quadruplicates to analyze the closed area in
% (mean +/− SD).
Generation of cell aggregates, determination of primary
aggregate formation
SKMEL28 cell suspensions (1 ml) were transferred
into sterile gas permeable biofoil bags (Biofoil,
Heraeus-Kulzer, Hanau, Germany) as described previ-
ously [13, 45]. Before sealing, either Wnt3a-
conditioned medium or PKF115–584 (0.5 μM) was
added into each bag. In the second set of experi-
ments, the siRNA-transfected SKMEL28 cells were
used without addition of drugs or conditioned
medium. Bags were sealed and placed in open
cylindrical plastic containers and were continuously
kept in constant rotation (2 rpm) for 24 h using a
roll mixer (Cellroll Integra Biosciences, Fernwald,
Germany) in a cell incubator at 37 °C with 95% air and 5%
CO2. To quantify the primary melanoma cell aggregation,
aggregates were next transferred into six-well-plates and
photographed with a microscope (Olympus IX50)
mounted camera (Olympus E330). For morphometric
analysis, 800–1200 aggregates per treatment were mea-
sured using AxioVision software (Zeiss, Oberkochen,
Germany). Results were statistically evaluated using One
way ANOVA, p-values of < 0.05 were considered as statis-
tically significant.
Primary melanoma cell migration
For determination of cell migration, the melanoma
aggregates were placed into six-well-chambers in culture
media (without de novo addition of Wnt3a or 0.5 μM
PKF115–584) and further incubated for 24 h at 37 °C in a
humidified incubator with 5% CO2. The aggregates
and their homogeneous cellular outgrowths were
photographed as described above. For morphometric
analysis, the area of the remaining aggregate and the
total area covering the aggregate plus the outgrown/mi-
grated cells (representing the migrated cells) were de-
termined in 200–300 aggregates per treatment group
using AxioVision software (Zeiss). The capacity for
migration (cell migration index) was calculated by dividing
the area of the cellular outgrowth by the size of the
aggregate and statistically evaluated (One way ANOVA)
with multiple comparison (Dunn’s multiple testing).
Luciferase reporter assay
For the assessment of Wnt/β-catenin signaling activ-
ity SKMEL28 melanoma cells were transfected with
the Super8xTOPFlash plasmid as described previously
[17, 46]. Cells were treated for 24 h before measur-
ing the luciferase activity which was normalized to
cell viability.
Quantitative real-time PCR
RNA isolation from melanoma cells was performed
using the NucleoSpin RNA Kit (Machery-Nagel, Dueren,
Germany) followed by reverse transcription using
Maxima reverse transcriptase (Thermo Fisher Scientific,
Dreieich, Germany) as recommended by the manufac-
turers. Reverse transcribed cDNA was subjected to SYBR
Green based real-time PCR as described previously [46]
using the following primers: INHBA forward 5′- agctcag
acagctcttaccaca-3″, INHBA reverse 5′ ttttccttctcctcttcag
ca-3′, CYR61 forward 5′-aaggagctgggattcgatg-3′. CYR61
reverse 5′- aggctccattccaaaaacag-3′. ANGPTL4 forward
5′- acgatggctcagtggacttc-3′. ANGPTL4 reverse 5′- cgtgatg
ctatgcaccttctc-3′, FABP7 forward 5′- aagtctgttgttagcctgga-
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3′, FABP7 reverse 5′- agggtcataaccattttgc-3′. CT values
were normalized to 18 S rRNA expression.
3D spheroid assay
SKMEL28 melanoma cell aggregates were formed over-
night before embedding the spheroids into a collagen
matrix with or without 3T3 / 3T3-Wnt3a fibroblasts
(1.5 × 105 cells/ml) and cultured using RPMI with
10% FCS. Sprouting (invasion) of SKMEL28 cells
was radially measured (n = 6) at 0 h and 48 h using
ImageJ, and an invasion index calculated as ratio of the
48 h to the 0 h value.
Organotypic skin reconstructs
Organotypic tissue skin reconstructs (TSR) were gener-
ated as described previously [40]. Briefly, human fibro-
blasts were seeded into a collagen type I (1.35 mg/ml)
matrix before the addition of an epidermal layer con-
sisting of HaCat keratinocytes and human melanoma
cells. TSR were exposed to control medium (3T3-con-
ditioned TSR medium) or Wnt3a-conditioned TSR
culture medium for 14 days before fixation and parrafine
embedding for immunohistochemical evaluation.
Preparation of eggs, transplantation procedures,
processing of the chick embryos
White leghorn chicken eggs were obtained from A. C.
Weiss GmbH&Co. KG (Kirchberg/Iller, Germany). Egg
handling and transplantations of SKMEL28 melanoma
cells into the neural tube (untreated (n = 8), Wnt3a-
preconditioned (n = 10), 0.5 μM PKF115–584-precondi-
tioned (n = 12)), of BLM melanoma cells into the
rhombencephalon (untreated (n = 8), 0.5 μM PKF115–
584-pretreated (n = 8)), or of SKMEL28 melanoma cells
into the rhombencephalon (control shRNA (n = 5),
β-catenin shRNA (n = 5)) of stage 12/13 chick embryos
according to Hamburger and Hamilton (HH) [47] were
performed as previously described [15, 39]. For the
shRNA experiment we used SKMEL28 cells with stable
knockdown of β-catenin [17]. Chick embryos were further
incubated after melanoma cell transplantation for 48 h
(neural tube) or 96 h (rhombencephalon), respectively.
For the chorioallantoic membrane (CAM) metastasis
assay eggs were incubated for 7 days at 38 °C with 60%
humidity. On day 7 of chick embryo development a
small window was made in the shell under aseptic
conditions. The window was resealed with adhesive tape
and eggs were returned to the incubator for 24 h. On
day 8, the CAM was gently abraded with a sterile cotton
swab to provide access to the mesenchyme and BLM
melanoma cell suspensions (5 × 105 cells) were seeded in
10 μl of PBS onto the upper CAM vasculature and
further incubated at 37.5 °C for 7 days. On day 15 chick
embryos were euthanized and CAM and livers removed
for isolation of genomic DNA (gDNA). Melanoma
cell derived human gDNA was detected by qPCR as
described elsewhere [42].
Immunohistochemistry and western blot
The following primary antibodies were used in this
study: anti-HMB-45 (1:20, Dako/ Agilent, Hamburg,
Germany), anti-β-catenin (#9562, 1:50, Cell Signaling
Technology, Leiden, Netherlands) and anti-Ki67/MIB1
(1:100, Dako/ Agilent). Immunohistochemistry of a
human melanoma tissue microarray (TMA) using an
anti-β-catenin antibody (1:100, Cell Signaling #9562)
was performed as described previously [46]. For western
blotting the following antibodies were used: anti-
Phospho-Akt (Ser473) (#4060), anti-Akt (#9272), anti-
PTEN (#9188), anti-beta-actin (#3700) (all Cell Signaling
Technology) and anti-beta-catenin sc-7963 (Santa Cruz).
All work with the TMA and human material was
approved by the local ethics committee (305/2017BO2).
Generation of Kaplan-Meier plots
Gene expression and clinical information were derived
from The Cancer Genome Atlas (TCGA, skin melanoma
dataset (n = 454)) (Network C.G.A., 2015). Patients were
subclassified according to gene expression values (e.g.
upper 11% and lower 11%). Five year survival rates were
evaluated with the log-rank test. Multivariate Cox
regression included gene expression, age, gender and
pathologic stage. The survival curves were visualized by
Kaplan-Meier plots.
Statistical analyses
Statistical analyses were performed with GraphPad
Prism 6.0 using the following tests: Fisher’s exact test,
One way ANOVA, Mann-Whitney. p-values < 0.05 were
considered as statistically significant.
Results
β-catenin is prominently expressed in primary human
melanomas at the invasive front
In our previous study, we demonstrated cytoplasmic
expression of β-catenin in human primary melanomas
using a melanoma tissue microarray [46]. We re-
evaluated the expression of β-catenin at the invasive
front in the primary melanomas. We could frequently
detect a strong expression of β-catenin in melanoma
cells at the invasive front (Fig. 1a). Interestingly, invasive
melanoma cells depicting a high expression of β-catenin
had a rather spindle-like, mesenchymal morphology.
This observation led us to hypothesize that Wnt ligands
and Wnt-signaling could be actively involved in melan-
oma cell invasion. Interestingly, analysis of the TCGA
melanoma data revealed a significant (p = 0.03) inverse
association of WNT3A gene expression with the five-year
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overall survival (OS) of melanoma patients when compar-
ing the specimens with the highest (top 11%, n = 50) with
lowest (bottom 11%, n = 50) gene expression (Fig. 1b). In
contrast, WNT5A gene expression did not reach signifi-
cance although the WNT5Ahigh group showed by trend a
reduced median OS of 1.70 years (p = 0.39). Further strati-
fication of the WNT3Ahigh and WNT3Alow melanoma
tumors by their PTEN expression levels yielded a re-
duced five-year overall survival (OS) for patients with
high WNT3A and low PTEN expression levels. The same
was found for WNT3 sharing 84% amino acid identy with
WNT3A. No significant difference in OS by PTEN stratifi-
cation was observed for WNT3Alow melanomas demon-
strating an important interaction of PTEN and the
activated Wnt signaling pathway in melanoma (Additional
file 1: Figure S1).
The agonist Wnt3a enhances, while the β-catenin
inhibitor PKF115–584 blocks neural crest migration of
melanoma cells in the chick embryo in vivo
To analyze whether Wnt signaling was involved in
neural crest cell migration of melanoma cells, we gener-
ated aggregates from a cell suspension of SKMEL28
melanoma cells kept in gas-permeable biofoil bags in
double rotation for 24 h. During aggregation, the cells
were cultured in control medium (3T3 conditioned) or
stimulated with conditioned medium of Wnt3a (agonist)
secreting 3T3 fiboblasts (Wnt3a-CM) or PKF115–584
(antagonist) to the medium. After 24 h, the aggregates
were transplanted into the embryonic neural tube of
stage 12/13 HH chick embryos. As shown previously [8],
48 h after transplantation control treated SKMEL28 cells
(immunohistochemically identified in the chick embryos
by anti-HMB45 staining) spontaneously integrated into
the roof plate of the neural tube in 6/8 transplanted
embryos and were detected mainly at proximal sites
along the medial neural crest migratory pathway
(Fig. 2a-c). A similar migration pattern was observed in
the Wnt3a-CM pre-conditioned SKMEL28 cells: integra-
tion into the roof plate and predominantly medial neural
crest migration in 8/10 transplanted embryos (p = 1.0,
Fisher’s Exact Test, compared to the control treated
cells; Fig. 2a-c). However, we detected an increased
number of single and clustered SKMEL28 melanoma
cells along distal sites of the medial neural crest cell
pathway close to the notochord and the developing
para-aortic sympathetic ganglia upon Wnt3a stimulation
(p = 0.0152, Fisher’s Exact Test). This is in line with the
Fig. 1 β-catenin is expressed in primary human melanomas in particular in cells of the invasive front. a Cytoplasmic expression of β-catenin in
primary melanomas. A stronger expression of β-catenin in melanoma cells of the invasive front was observed by immunohistochemistry when
compared to the bulk cells of the primary melanoma. Melanoma cells of the invasive front with a high expression of β-catenin had a spindle-like,
mesenchymal morphology. Overview (upper row) and higher magnification of the invasive front (lower row) of four representative primary
melanomas. b Overall survival (OS) analysis of the TCGA data set for the top and bottom (n = 50 each) WNT3A and WNT5A expressing
melanomas reveal a significantly worse OS for WNT3A-high (p = 0.03) but not WNT5A-high melanoma patients (p = 0.39)
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previously described enhanced neural crest migration of
B16-F1 melanoma cells upon stimulation with BMP-2 [13].
PFK115–584 pre-conditioned SKMEL28 cells showed a
completely different result: 48 h after transplantation into
the neural tube the cells had formed compact tumor
nodules in the dorsal lumen of the neural tube and were
attached to and integrated into the roof plate and the adja-
cent mesenchyme between the roof plate and the surface
ectoderm (Fig. 2a-c). However, only in 1/12 of transplanted
embryos we detected few single emigrating cells along the
proximal medial neural crest cell pathway in direct vicinity
to the lateral roof plate (p = 0.0044, Fisher’s Exact Test,
compared to the untreated cells). To confirm the viability
of the melanoma cells, we performed anti-Ki67 (MIB1)
immunohistochemistry. Almost all melanoma cells in the
chick embryo were MIB1-positive, clearly demonstrating
c
distal medialdistal lateral
proximal medial
distal medial
a
b
Fig. 2 Wnt3a enhances and PKF115–584 blocks neural crest migration of SKMEL28 melanoma cells in the chick embryo in vivo. a Control treated
(n = 8), Wnt3a (n = 10) or 0.5 μM PKF115–584 (n = 12) pre-conditioned SKMEL28 melanoma cell aggregates were injected into the neural tube of
stage 12/13 HH chick embryos and further incubated for 48 h. Embryos were formalin-fixed and paraffine-embedded (FFPE) before sectioning
and staining for HMB45 (red) to identify the SKMEL28 melanoma cells. In 6/8 embryos, untreated HMB45-positive SKMEL28 cells integrated into
the roof plate of the neural tube and migrated mainly along the proximal medial neural crest cell pathway. Wnt3a pre-conditioned SKMEL28
cells similarly integrated into the roof plate and predominantly performed medial neural crest migration in 8/10 embryos (not significant, Fisher’s
Exact Test, compared to the untreated cells). An increased number of HMB45-positive Wnt3a pre-conditioned cells were detected along the distal
medial neural crest cell pathway close to the notochord and the developing para-aortic sympathetic ganglia. 0.5 μM PFK115–584 pre-conditioned,
HMB45-positive SKMEL28 cells formed compact tumor nodules in the dorsal lumen of the neural tube and were attached to and integrated into the
roof plate and the adjacent mesenchyme between the roof plate and the surface ectoderm. Only in 1/12 embryos single emigrating cells
were detected along the proximal medial neural crest cell pathway in direct vicinity to the lateral roof plate (p < 0.01, Fisher’s Exact Test,
compared to the untreated cells). b Scheme showing the neural crest-like migration patterns of melanoma cells out of the roof plate after
injection into the neural tube. c Quantification of chick embryos showing SKMEl28 melanoma cells that migrated to proximal or distal sites of the medial
migration pathway after different pre-treatments (asterisks define p-values calculated by Fisher’s exact test)
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the proliferative activity and viability of the transplanted
cells (Additional file 1: Figure S2A). Immunohistochemical
staining with anti-β-catenin showed that the PKF115–584
pre-treatment caused a reduced cytoplasmic expres-
sion of β-catenin in the HMB45 positive melanoma
cells (Additional file 1: Figure S2B).
Wnt3a increases and PKF115–584 decreases melanoma
cell migration
To analyze the impact of Wnt stimulation and inhibition
on melanoma cell migration, we conducted wound
closure experiments (scratch assays) with serum-starved
human SKMEL28 (upper row) and A375 (lower row)
melanoma cells (Fig. 3a). The cells were either left
untreated (untreated control), pre-conditioned with
3T3-medium (3T3-CM), Wnt3a-3T3 medium (Wnt3a-
CM), or for 4 h with 0.5 μM PKF115–584. The wound
was photographed at 0 h, 12 h and at 24 h, and the closed
area (migrated cells) was morphometrically measured.
After 24 h, we observed significantly increased migration
upon stimulation with Wnt3a-CM, and a significantly
decreased migration upon treatment with PKF115–584.
To that effect there is a clear impact of fibroblast derived
Wnt3a on melanoma cell migration. A 4 h treatment with
0.5 μM PKF115–584 did not dramatically reduce
melanoma cell viability within 24 h after scratching
(Additional file 1: Figure S3). However, massive cell
death was observed when the incubation was prolonged,
confirming our former studies [17]. A third cell line
SKMEL19 showed the same trend, however the increased
wound closure upon Wnt3a-CM treatment was not sig-
nificant (Additional file 1: Figure S3A). Scratch assay using
co-cultured fluorescence-labeled 3T3 and 3T3-Wnt3a
fibroblast cells with 451Lu, BLM or A375 melanoma cells
confirmed our findings (Additional file 1: Figure S3B).
Interestingly, also the Wnt3a producing 3T3 cells
a
b Ctrl. Wnt3a PKF115-584
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Fig. 3 Wnt3a induces and PKF115–584 inhibits migration and typical features of EMT of melanoma cells in vitro. a Scratch assay of human SKMEL28
(upper row) and A375 (lower row) melanoma cells showing increased migration upon stimulation with Wnt3a conditioned medium (Wnt3a CM)
and decreased migration upon treatment with PKF115–584) when compared to untreated and 3T3-medium conditioned cells (3T3-CM). b Upper
row/ Aggregation: Aggregates were generated from SKMEL28 cells (untreated, or stimulated by Wnt3a or 0.5 μM PKF115–584 during aggregation),
photographed and measured after 24 h. Wnt3a decreased and PKF115–585 increased the aggregate size (*: p < 0.05; ***: p < 0.001, One way ANOVA).
Depicted: aggregate size in μm2±SD. Lower row/ Outgrowth: The SKMEL28 aggregates were re-incubated for 24 h in 6-well-plates and photographed.
Around each aggregate a single layered outgrowth of emigrating cells had formed. The areas of aggregates and cellular outgrowths were measured
and the migration capacity (cell migration index) determined by dividing the area of the outgrowth by the area of the aggregate. Wnt3a increased
and PKF115–584 decreased the cell migration index (***: p < 0.001, One way ANOVA). Depicted: cell migration index±SD
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themselves exhibited an increased migratory potential into
the gap of the wound compared to the 3T3 control cells.
Wnt3a decreases and PKF115–584 increases aggregation
of melanoma cells
During neural crest induction EMT is characterized by two
important morphological steps: (i) delamination or de-
crease of adhesion (ii) induction of migration. To analyze
these two steps (adhesion and migration) in more detail in
a more physiological 3D–environment, we performed two
sets of experiments in vitro. In the first experiment, we de-
termined whether Wnt-signaling influenced melanoma cell
aggregation. To this end we generated aggregates as
described above. The cells were either left untreated or
stimulated by the addition of Wnt3a-CM (agonist) or
PKF115–584 (antagonist) to the medium. After 24 h, the
spontaneously generated aggregates were photographed
and measured (Fig. 3b, upper row). The control SKMEL28
cells homogenously formed aggregates (n = 962 measured
aggregates, 3863 ± 646 μm2). We found a significantly de-
creased aggregate size by 26% after exposure of the
SKMEL28 cells to the agonist Wnt3a (n = 1199 measured
aggregates, 2823 ± 485 μm2) and a significantly increased
aggregate size after exposure to the antagonist PKF115–
585 (n = 792 measured aggregates, 26,537 ± 4927 μm2).
Wnt3a increases and PKF115–584 decreases primary
melanoma cell migration in vitro
To test the second step of EMT (induction of migra-
tion), we performed a cell outgrowth assay comparable
to the original description of embryonic EMT in vitro
[6]. SKMEL28 aggregates generated after 24 h of aggre-
gation time as above (either untreated, conditioned with
Wnt3a-CM or pre-treated with PKF115–584) were
seeded into 6-well-plates, incubated for another 24 h (in
new medium without further stimulation, with either
Wnt3a or PKF115–584), and photographed. Around the
Wnt3a preconditioned and untreated SKMEL28 aggre-
gates a pronounced coherent, single layered outgrowth
of emigrating cells had formed, which was less promin-
ent in the PKF115–584 treated group (Fig. 3b, lower
row). For quantitative evaluation, the areas of aggregates
and respective outgrowths were measured by morphom-
etry. Wnt3a significantly increased the cell migration
index (n = 100 aggregates measured, 18.42 ± 9.23 [a.u.])
and PKF115–584 significantly decreased (n = 313 aggre-
gates measured, 1.38 ± 0.2 [a.u.]) the cell migration index
of SKMEL28 aggregates when compared to the control
group (n = 90 aggregates measured, 5.80 ± 2.01 [a.u.]).
Wnt3a enhances melanoma cell invasion in organotypic
skin reconstructs
Similarly, melanoma cells that were seeded together with
HaCat keratinocytes onto the dermal part of organotypic
tissue skin reconstructs (TSR) showed increased invasion
of melanoma cells into the dermis when the medium was
pre-conditioned by Wnt3a-producing fibroblasts (3T 3
cells) in comparison to the conditioning with control
3T3 cells. This effect was seen using BLM, A375 and
451Lu melanoma cells (Fig. 4a and Additional file 1:
Figure S2). Knockdown of β-catenin using a lentiviral
shRNA vector abolished the invasive capacity of the
melanoma cells independent of the preconditioning of
the medium (Fig. 4b and Additional file 1: Figure S2).
Additional immunoflourescence stainings of TSR with
HMB45-positive 451Lu cells revealed that melanoma
cells mostly resided in the epidermal layer with keratino-
cytes when TSR were treated with 3T3-conditioned
medium or after knockdown of β-catenin. In contrast,
Wnt3a-conditioned medium induced a more invasive
phenotype of the 451Lu cells including invasion into the
dermal (collagen type I) matrix. Staining for β-catenin
showed the typical membranous staining in the HaCat
epidermal layer. After the knockdown by lentiviral expres-
sion of CTNNB1 specific shRNA in the 451Lu melanoma
cells a reduced cytoplasmic and nuclear protein level
became evident when compared with invading 451Lu
melanoma cells that showed a higher expression of cyto-
plasmic and nuclear β-catenin (Fig. 4a-b).
A common set of genes is expressed during neural crest
induction in the zebrafish embryo and upon Wnt
induction in SKMEL28 melanoma cells
To further elucidate whether a common set of genes
was expressed during neural crest induction in the
zebrafish embryo and in human melanoma cells upon
Wnt3a stimulation, we conducted mRNA expression
analyses of human SKMEL28 melanoma cells (untreated,
Wnt3a, or PKF115–584 pre-conditioned) and of isolated
zebrafish embryo neural crest. Forty four overlapping
genes were unanimously differentially expressed in
SKMEL28 after treatment with Wnt3a or Wnt−/β-ca-
tenin inhibition by PKF115–584 (Additional file 2: Table
S1 and Additional file 1: Figure S5A). By comparing
these 44 genes to the gene expression pattern of the
zebrafish neural crest, we found an overlap of the follow-
ing six genes: GTP binding protein over-expressed in
skeletal muscle (GEM), angiopoietin-like 4 (ANGP
TL4), dual specificity phosphatase 5 (DUSP5), pleck-
strin homology-like domain, family A, member 2
(PHLDA2), interferon-induced protein 44 (IFI44), and
fatty acid binding protein 7 (FABP7).
A comparison of the 44 differently expressed genes
with the gene expression patterns of distinct melanoma
cell phenotypes as determined by Hoek et al. (invasive
or proliferative, [48]) revealed an overlap of three genes
(cysteine-rich, angiogenic inducer, 61 (CYR61), angiopoietin-
like 4 (ANGPTL4), and inhibin beta A (INHBA)). All
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three were significantly upregulated in cells with an
invasive phenotype (Additional file 1: Figure S5B). Out of
these eight candidate genes we chose four candidates with
a possible impact on EMT in the melanoma cells for
further investigation: INHBA, FABP7, ANGPTL4, and
CYR61. The increased expression in three of the genes in
the invasive cell lines compared to the proliferative cell
lines is in contradiction with the up-regulation after
Wnt3a-CM stimulation in SKMEL28 cells and our ob-
served pro-migratory effects. It is important to know that
the phenotypes used by Hoek et al. were based on
different model systems compared to our experiments.
However, they revealed genes that are involved in the
biology of melanoma cells.
To test the functionality of our cell treatments we used
a firefly luciferase reporter assay (Super8xTOPFlash)
which measures the transcriptional activity of canonical
Wnt signaling. As expected, treatment of the SKMEL28
melanoma cells with Wnt3a-conditioned medium but
not with 3T3-conditioned medium induced the transcrip-
tional activity of the Wnt/β-catenin signaling pathway
(Fig. 5c). Moreover, treatment with 0.5 μM PKF115–584
for 12 h more than halved the luminescence signal in
the reporter assay indicating the inhibitory effect of
Fig. 4 Wnt3a induces invasive growth of melanoma cells in organotypic tissue skin reconstructs (TSR). a 451 LU melanoma cells were
seeded together with HaCat epidermal cells onto a layer of collagen I embedded human fibroblasts. TSR exposed to Wnt3a conditioned medium
(Wnt3a-CM) showed a pronounced invasive morphology in the H&E staining (upper pictures) when compared to cells exposed to control medium
(3T3-CM). Immunofluorescence stainings for HMB45 (red) and beta-catenin (blue) identified melanoma cells (HMB45+), revealed beta-catenin
expression levels and verified the invasion of single 451 LU cells from the epidermis (epi) into the dermal part (der). Nuclei were stained
with YO-PRO-1 (green). b Knockdown of beta-catenin (blue) with shRNA (shCTNNB1) reduced the invasion of 451 LU melanoma cells (HMB45+, red)
into the dermal part of the TSR
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Fig. 5 Gene expression during neural crest induction in the zebrafish embryo and upon Wnt stimulation in SKMEL28 melanoma cells, and clinical
significance. a Heatmaps of real-time qPCR gene expression analysis of the melanoma cell lines SKMEL19, 451 LU, BLM and A375 for AXIN2. TYR,
MITF and the four genes INHBA, CYR61, ANGTPL4 and FABP7. Log2 transformed x-fold expression values were used for color-coding. Yellow:
upregulated gene expression; blue: downregulated gene expression at 24 h treatment of the melanoma cells; black: not detectable b Western
blot analysis to detect protein levels of beta-catenin, PTEN, phospo-Ser473 (AKT) and AKT in the melanoma cell lines A375, SKMEL19, BLM and 451 LU
after treatment with 3T3-CM, 3T3-Wnt3a, or 0.5 μM PKF115–584 for 24 h. Beta-actin was used as loading control. Small-hairpin knockdown cells served
as samples to investigate the dependence on beta-catenin. c Luciferase reporter assay (Super8xTOPFlash) indicates a 3-fold activation of the canonical
Wnt−/β-catenin signaling pathway after stimulation of SKMEL28 cells with Wnt3a-conditioned medium (3T3-Wnt3a). PKF115–584 treatment (0.5 μM for
12 h) significantly inhibited reporter activity. **: p < 0.01, ***: p < 0.001, One way ANOVA
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PKF115–584 on the Wnt/β-catenin signaling pathway.
Another method to measure the activity of the Wnt/
β-catenin signaling pathway is the quantitative RNA
expression analysis of the target gene AXIN2 by real-
time qPCR. Treatment of four different melanoma
cell lines with Wnt3a-CM induced AXIN2 expression
in comparison with 3T3-CM treated melanoma cells
(Fig. 5a). Vice versa knockdown of β-catenin reduced
in three out of four cell lines the expression of AXIN2,
again confirming the interfering of our treatments with
the Wnt/β-catenin signaling pathway. MITF expression
was only slightly induced by Wnt3a-CM and an increased
expression of TYR could only be detected in SKMel19
and 451 LU cells. TYR was not detectable in A375 and
BLM melanoma cells. The down-regulation of INHBA,
CYR61 and ANGPTL4, which was found in SKMEL28
melanoma cells after treatment with Wnt3a-CM could be
confirmed in these four cell lines by real-time qPCR when
compared to the 3T3-CM samples. FABP7 was found
to be up-regulated, again supporting the results obtained
from SKMEL28 melanoma cells (Fig. 5b). On protein level
the treatment of melanoma cells with Wnt3a-CM
increased β-catenin expression whereas PKF115–584
treatment reduced β-catenin as expected. Interestingly,
all melanoma cell lines and all conditions showed an
activation of the PI3K signaling pathway as indicated by
phosphorylated Ser473 of AKT although only BLM did
not express PTEN in clearly detectable amounts (BLM
is known to have a methylated PTEN promoter).
PKF115–584 induced further AKT phosphorylation
which hints at a putative counter regulation to the
reduced β-catenin levels, since GSK3 is a target of AKT
and Ser9 phosphorlyation of GSK3 stabilizes β-catenin.
Since we observed a close correlation between the
Wnt3a-CM or PKF115–584 treatment and the expression
of pigmentation related genes (DCT, TYR, TYRP1, MITF)
in our SKMEL28 microarray data, we analyzed the TCGA
melanoma RNAseq expression data concerning MLANA
expression. We chose the top and bottom 11% (n = 50) of
melanomas in terms of MLANA expression and identified
the differentially expressed genes considering our 44
differentially expressed genes. We found 22/44 of our
identified genes (including INHBA, CYR61 and ANGPTL4)
to be significantly co-expressed (Additional file 2: Table S1).
This supports the biological in vivo relevance of our
investigated gene pattern in melanoma.
siRNA knock-down confirms the double role of genes
simultaneously involved in embryonic neural crest
induction and melanoma cell EMT
In a next step, we down-regulated the four selected
genes above (INHBA, CYR61, ANGPTL4, andFABP7)
using siRNA in SKMEL28 cells to analyze their possible
influence on melanoma cell adhesion and migration. We
observed a significant decrease of aggregate size for the
knockdown of INHBA, ANGTPL4 and to a lesser extent
for FABP7 (siCtrl: n = 440 measured aggregates, 30,206
± 14,892 μm2; siINHBA: n = 643 measured aggregates,
19,668 ± 10,191 μm2; siFABP7: n = 516 measured aggre-
gates, 27,421 ± 13,718 μm2; siANGPTL4: n = 356 measured
aggregates, 24,921 ± 9825 μm2; siCYR61: n = 720 measured
aggregates, 30,531 ± 12,064 μm2; one-way ANOVA,
Fig. 6a, b). These results suggest a role in melanoma
cell adhesion for INHBA, and ANGPTL4. More important
and mostly in line with our previous data (but oppos-
ing the data of Hoek et al. (Fig. 3b, Additional file 1:
Figure S5B)), we detected a significantly increased
outgrowth and thereby migration capacity for all four
different knockdown conditions, especially with siRNA
specific for INHBA, ANGPTL4 and CYR61 (siCtrl: n = 56
aggregates measured, 7.82 ± 2.88 [a.u.]; siINHBA: n = 36
aggregates measured, 12.56 ± 4.58 [a.u.]; siFABP7: n = 50
aggregates measured, 10.10 ± 3.93 [a.u.]; siANGPTL4:
n = 46 aggregates measured, 10.58 ± 3.82 [a.u.]; siCY
R61: n = 69 aggregates measured, 10.35 ± 4.0 [a.u.],
Fig. 6a and b). This demonstrates a regulatory function for
INHBA, FABP7, ANGPTL4, and CYR61 in melanoma cell
migration. The least effect was again detected for the
knockdown of FABP7. Since we also measured increased
migratory behavior after knockdown of FABP7 (although
this gene was upregulated with Wnt3a-CM treatment) a
composite of gene expression alterations after Wnt3a-CM
might be responsible for the effect of increased migration
and reduced homotypic cell adhesion.
Next, we investigated a possible impact of the four se-
lected genes (INHBA, FABP7, ANGPTL4, and CYR61)
on overall survival of melanoma patients [49]. For this
purpose, we analyzed melanoma gene expression levels
and clinical information from The Cancer Genome Atlas
(TCGA, skin melanoma dataset (n = 454)) [50]. The
survival curves of CYR61 and INHBA were visualized by
Kaplan-Meier plots (Fig. 6c). Indeed, a high expression
(upper and lower 22%, n = 100 per group) of CYR61 in
primary melanomas was significantly associated with
increased 5-year overall survival in the corresponding
patients (median OS of 3.57 versus 2.10 years). We detected
a strong trend for increased overall survival for patients
with primary melanomas bearing a high expression level
(median OS of 3.67 versus 2.0 years; n = 50 per group) of
INHBA (Fig. 6c). No differences in OS were found for
ANGPTL4 and FABP7 stratifications (data not shown).
β-catenin is expressed in the cytoplasm of malignantly
invading melanoma cells during brain metastasis
in vivo in the chick embryo; the β-catenin antagonist
PKF115–584 potently inhibits metastasis
Next, we sought to determine if the inhibition of the
Wnt-signaling pathway with PKF115–584 also had an
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impact on tumor formation, malignant invasion of mel-
anoma cells and metastasis in vivo. We transplanted un-
treated (n = 8) or PKF115–584 pre-conditioned (n = 8)
human BLM melanoma cell aggregates generated as de-
scribed above into the IVth ventricle (rhombencephalon)
of the stage 12/13 HH chick embryo, and analyzed the
embryos for possible tumor formation and invasion after
an additional 96 h of incubation. Analogous to former
results [39], the untreated BLM cells formed small
tumor nodules in the roof plate of the rhombencephalon
and infiltrated the neighboring host tissues (Fig. 7a).
Since BLM cells are HMB45-negative the neural crest
marker p75 was used for melanoma cell identification
(Fig. 7b). Close to 100% of the BLM cells were MIB1-
positive (Fig. 7c). We detected a high number of invad-
ing BLM cells in close vicinity to blood vessels (Fig. 7d)
and some BLM cells had even entered the vasculature
and thus actively metastasized by transendothelial mi-
gration (Fig. 7e). This is in line with the reported melan-
oma cell angiotropism during metastasis [51] and the
role of β-catenin in transendothelial migration [52].
To determine the role for β-catenin during tumor
Fig. 6 siRNA knock-down confirms the double role of genes simultaneously involved in embryonic neural crest induction and melanoma cell
adhesion. a SKMEL28 cells aggregated during 24 h of roller culture after knockdown of the four gene candidates (upper row) and were
microphotograped (10X magnification) Further cultivation of the aggregates for 24 h was used to detect the outgrowth of migratory cells
(10X magnification). b For all four knocked-down genes a significant decrease of aggregate size (left diagram) compared to the siCtrl
SKMEL28 cells was observed (ns: not significant, **: p < 0.01, ****: p < 0.0001, One way ANOVA). Depicted in red: mean aggregate size in μm2±SD.
An increased cell migration index (right diagram) was detected for all four knocked-down genes in the transfected SKMEL28 cells compared to siCtrl
SKMEL28 cells (*: p < 0.05, **: p < 0.01, ****: p < 0.0001, One way ANOVA). Depicted in red: mean cell migration index±SD. c Kaplan-Meier plots of
CYR61- or INHBA-expression in primary melanomas demonstrating a correlation of gene expression with overall survival of melanoma-afflicted patients
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formation and invasion of BLM cells in the chick brain, we
stained serial sections for β-catenin. Immunohistochemistry
revealed that in the tumor nodule the MIB1-positive,
proliferating, centrally located BLM cells depicting a
compact, epithelial-like morphology (Fig. 7c) had only a
weak cytoplasmic expression of β-catenin (Fig. 7f, parallel
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Fig. 7 Expression of β-catenin in BLM melanoma cells during brain metastasis in vivo. Untreated (n = 8) or 0.5 μM PKF115–584 pre-conditioned
(n = 8) human BLM melanoma cell aggregates were injected into the IVth ventricle (rhombencephalon) of the stage 12/13 HH chick embryo (m).
After 96 h of further incubation the embryos were analyzed for tumor formation and melanoma cell invasion. a Untreated BLM cells had formed
small tumor nodules in the roof plate of the rhombencephalon and infiltrated the neighboring host tissues in 7/8 chick embryos. b The HMB45-negative
BLM cells the neural crest marker p75 (red cytoplasmic staining). c-e: BLM cells were almost 100% MIB1-positive (red nuclear staining) and were detected
close to (d) or within (e, arrows pointing at BLM cells) blood vessels. f-i Immunohistochemistry for anti-β-catenin (f, red staining) showed that in
the central tumor nodule as well as the metastatic nodule in the region of the floor plate the MIB1-positive BLM cells with a compact,
epithelial-like morphology (asterisks in g and h) had only a weak cytoplasmic expression of β-catenin, while the cells in the outskirt of
the tumor nodule and cells invading the host tissues in the mesenchyme along the neuroepithelium with a stretched, mesenchymal-like
morphology (arrows in g and i) showed a prominent β-catenin expression. j-l In 8/8 embryos injected with PKF115–584 pre-conditioned
BLM cells only an empty space as reminder of the former tumor nodule was detected after 96 h (j, k). Only few PKF115–584 pre-conditioned,
MIB1-negative BLM cells and aggregates with morphological signs of apoptosis could be distinguished at this point in the lumen of the
IVth ventricle floating among cellular debris of dead BLM cells (l). m Scheme of the injection of melanoma cells into the rhombencephalon of chick
embryos. n Qualitative enumeration of chick embryos showing viable BLM melanoma cells in the roof plate with invading melanoma cells as shown
in A-L. (asterisks define p-values calculated by Fisher’s exact test)
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slide of Fig. 7c), while the cells in the outskirt of the tumor
nodule with a spindle-like, invasive morphology showed a
more prominent cytoplasmic β-catenin expression
(Fig. 7g, compare to Fig. 1). The same phenomenon
could be observed in the region of the floor plate of
the rhombencephalon, where invading BLM cells had
already formed a secondary tumor nodule/metastasis.
Here too, compact, epithelial-like cells had only a weak,
and stretched, mesenchymal-like cells a more prominent
cytoplasmic β-catenin expression (Fig. 7h). Single BLM
cells with a similar stretched, mesenchymal morphology
invading the host tissues in the mesenchyme along the
neuroepithelium again showed a prominent expression of
β-catenin (Fig. 7i, compare Fig. 1).
Further, we observed that in all eight transplanted
embryos the BLM cells pre-treated with the β-catenin
inhibitor PKF115–584 had obviously formed a tumor
nodule at the dorsal midline of the roof plate in the IVth
ventricle (as expected), but had subsequently mostly
died, leaving only an empty space as reminder of the
former tumor nodule (Fig. 7j, k). The few remaining
PKF115–584 pre-conditioned cells were floating among
cellular debris of dead BLM cells in the lumen of the
IVth ventricle and showed no signs of proliferation
(negative for Ki67/MIB1, Fig. 7l).
To test whether the infiltration of single melanoma
cells from aggregates observed in the neural crest or the
rhombencephalon could be reproduced in a similar
3D–environment in vitro, we embedded SKMEL28
melanoma cell aggregates into a collagen matrix with
or without 3T3 cells or Wnt3a secreting 3T3-Wnt3a cells
as stroma. Sprouting (invasion) of SKMEL28 cells was ra-
dially measured (n = 6 per treatment group) at 0 h and
48 h. Stromal cells (3T3) increased sprouting of SKMEL28
cells, and this effect was significantly more pronounced in
the 3T3-Wnt3a stromal environment (Fig. 8a), thus con-
firming the in vivo results described above.
To validate our findings with BLM melanoma cells in
the chick brain, we conducted a confirmation experi-
ment using SKMEL28 melanoma cells with a stable
knock-down of β-catenin via shRNA [17]. As expected,
in control shRNA SKMEL28 cells, tumor nodules
formed in the roof plate of the rhombencephalon, and
single cells infiltrated the neighboring host tissues
(Fig. 8b and c; compare Fig. 7a and sprouting in Fig. 8a).
The β-catenin shRNA SKMEL28 cells showed a different
result: Here, the tumor cells had formed aggregates
attached to the roof plate, without infiltration of the host
tissue (Fig. 8d and e), thus corroborating the results
obtained with PKF115–584.
Besides invasion, metastasis comprises several additional
steps like intra- and extravasation. Therefore, we per-
formed an in ovo chorioallantoic membrane (CAM)
metastasis assay using chick embryos. Control BLM
cells or PKF115–584 pretreated (0.5 μM for 2 h) BLM
cells (1 × 106 cells in 10 μl) were seeded onto the CAM of
8 day chick embryos and further incubated for 7 days.
Then the upper CAMs containing the melanoma tumors
and the livers with putative micrometastases were
harvested and analyzed by qPCR for human DNA.
Whereas the short pre-treatment with PKF115–584
did not significantly affect the initiation and growth
of tumors at the side of inoculation (p= 0.8, Mann-Whitney
test), the number of micrometastatic cells in the livers of
chick embryos in the PKF115–584 group was significantly
reduced (p = 0.002, Mann-Whitney test). This strongly
highlights the importance of Wnt−/β-catenin signaling
during metastasis of melanoma cells.
Discussion
In the present study, we demonstrate a novel role of
Wnt3a and the β-catenin signaling pathway in neural
crest migration and malignant invasion of human mel-
anoma cells.
Current therapeutic strategies for the treatment of
metastatic melanoma focus on two major approaches
with proven clinical efficacy: (i) direct targeting of
activated oncogenes in melanoma cells such as BRAF
[53] or (ii) indirect targeting of melanoma cells by T-cell
stimulation with anti-CTLA4- or anti-PD-1-antibodies
[54, 55]. Although these therapies caused a paradigm
shift and were able to improve the 3-years overall
survival of patients diagnosed with metastatic melanoma
between 2011 and 2014 to 23% [56], both approaches
bear major drawbacks, which are reflected by the limited
duration of the initial clinical response. Only a subpopu-
lation of melanomas harbors the crucial oncogenic
BRAF-mutation, and even in mutated melanomas a ther-
apy resistance rapidly develops [57]. We have recently
shown that β-catenin is one potent mediator of resist-
ance towards BRAF inhibition [46]. In line, high levels of
ZEB1 expression (an EMT inducer) are associated with
inherent resistance to MAPKi in BRAFV600-mutated
cell lines and tumors [58]. Likewise, only a half of the
patients clinically responds to T-cell stimulation, which
is at least partially due to the fact that cytotoxic CD8+
T-cells only recognize major histocompatibility complex
(MHC) class I (MHC-I)-expressing melanoma cells.
However, the alteration of MHC-I expression together
with an impaired response to interferons is a frequent
event during cancer (and melanoma) progression, allow-
ing cancer cells to evade the endogenous or therapeutic
immunosurveillance [59]. A second plausible explan-
ation for resistance to the novel immunotherapies might
be the tumor-intrinsic oncogenic signals such as active
β-catenin signaling, that mediate T-cell exclusion at the
site of the tumor and thus resistance to anti-PD-L1/anti-
CTLA-4 therapy [38, 60]. Such mechanisms might be
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reflected by the association of WNT3A expression and
melanoma patient survival which we have elaborated in
this project. Therefore, additional and fundamentally
different therapeutic approaches are still desperately
needed to improve therapies and finally overall- and
long-term survival of advanced melanoma patients.
Our approach is to draw an analogy between embryonic
growth and cancer growth. In particular, neural crest signal-
ing pathways seem to be a promising target for the inhib-
ition of melanoma cell invasion and metastasis [14].
Therefore, in the current study we first addressed the spatial
expression of β-catenin in primary human melanomas.
Interestingly, we found that β-catenin was predominantly
expressed in melanoma cells of the invasive front with a
spindle-like morphology. Therefore, we hypothesized that
β-catenin-inhibition could affect melanoma cell migration
and invasion in the neural crest. In the embryo, emigra-
tion of neural crest cells from the neural tube is desig-
nated as EMT. EMT represents a complex change in cell
morphology and migratory potential of embryonic cells
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Fig. 8 Knock-down of β-catenin with shRNA in SKMEL28 cells inhibits brain metastasis formation in the rhombencephalon of the chick embryo.
a SKMEL28 aggregates were embedded into a collagen matrix with or without 3T3 or 3T3-Wnt3a stroma cells. Sprouting of SKMEL28 cells was
measured at 0 h and 48 h, and an invasion index calculated as ratio of the 48 h to the 0 h value. 3T3 stroma cells, and more prominently,
3T3-Wnt3a stroma cells increased sprouting of SKMEL28 cells (**: p < 0.01; ***: p < 0.001, One way ANOVA). b Control shRNA (n = 5) or
shCTNNB1 (n = 5) SKMEL28 aggregates were injected into the IVth ventricle of the stage 12/13 HH chick embryo, and analyzed after
96 h of further incubation as above. SKMEL28 control shRNA cells formed tumor nodules in the roof plate and neighboring host tissues with single
infiltrating cells resembling the sprouting cells in (a). Knock-down of β-catenin via shRNA (shCTNNB1) completely blocked invasion of melanoma cells
in the rhombencephalon. c BLM cells were used in the CAM metastasis assay. Pre-exposure of the BLM cells with PKF115–584 (0.5 μM for 2 h)
significantly reduced liver micrometastasis but showed no effect on primary tumor formation on the CAM (Mann-Whitney test)
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and is induced in the embryo mainly by BMPs and Wnt-
signaling [1–4], and vice versa inhibited by their antago-
nists. EMT comprises two consecutive steps [61, 62]:
(i) the neural crest compartment is induced in the
epithelium of the neural tube, which is morphologically
characterized by the disintegration of the basal lamina in
the region of the lateral roof plate. (ii) Neural crest cells
are induced to start migration from the dorsal edges of
the neural tube along their designated medial and lateral
pathways. Hence, EMT (governing embryonic neural crest
migration and possibly melanoma cell invasion in the
patient) of melanoma cells as neural crest descendants
should be analyzed in the neural crest environment.
To verify our analogy hypothesis, we therefore used
our chick embryo model in two different experimental
settings: First, we injected human melanoma cells into
the lumen of the neural tube of stage 12/13 HH chick
embryos to analyze their capacity for spontaneous neural
crest migration. Before injection, the melanoma cells
were pre-conditioned with either the agonist Wnt3a or
with the β-catenin-inhibitor PKF115–584. Interestingly,
the agonist and the antagonist had opposing impacts on
melanoma cell behavior in the neural crest compart-
ment: Wnt3a enhanced, and PKF115–584 abrogated the
spontaneous neural crest migration of SKMEL28 cells in
vivo, which is in line with the effects of the neural crest-
inducer BMP-2 and its physiological antagonist noggin
[13]. The impact of Wnt-signaling on melanoma cell mi-
gration and EMT (reflected by changes in aggregation
and migration) could be reproduced in vitro. This find-
ing is challenged by several publications that rather show
the opposite effects [26–29]. However, a recent study
clearly showed that canonical Wnt signaling is a pro-
invasive factor in the context of active PI3K signaling
pathway due to PTEN deficiency [63]. This effect was
found to be mediated by context dependent regulation
of catabolic processes by β-catenin. Since in our cell cul-
ture models the PI3K signaling pathway is activated
(high phosphorylation of Ser473 of AKT) we believe that
our models reflect this situation. This is further substan-
tiated by the bad impact of low PTEN expression levels
on melanoma patient survival in the context of a high
expression of WNT3A (whereas PTEN levels have no
impact on survival for WNT3A low melanomas).
RNA expression analyses of melanoma cells pre-
conditioned with either Wnt3a or PKF115–584, and of
zebrafish embryo neural crest cells demonstrated over-
lapping genes. Using siRNA mediated down-regulation,
we could functionally demonstrate an impact on EMT
of the overlapping genes in melanoma cells in vitro, thus
corroborating the RNA-expression results. In this
respect, we were able to identify inhibin beta A as novel,
β-catenin-regulated candidate gene that hinders melan-
oma cell invasion. Interestingly, by screening melanoma
data from The Cancer Genome Atlas, we discovered a
correlation of high expression of CYR61 or (by trend)
INHBA with increased overall survival of melanoma
patients, clearly underlining the clinical significance of
our findings. This is in line with a previous report show-
ing that Cyr61 expression in melanoma cells reduces
tumor growth and metastasis [64].
Since we also detected MITF and its target gene tyro-
sinase (TYR) to be regulated upon modification of
canonical Wnt signaling in SKMEL28 melanoma cells it
could be that MITF is at least partially involved in the
pro-migratory effects in vitro and in vivo. This would
support a recent publication, which found that MITF is
required for melanoma cell migration and invasion inde-
pendent of BRN2, meaning in MITFhigh and MITFlow
melanoma cells [65]. Again, this is a topic full of con-
flicting data which is mirrored by the complexity of the
MITF rheostat model [66]. For example, Fane et al.
could recently show that MITF and BRN2 are inversely
correlated and BRN2 expression drives melanoma cell
migration and invasion via the nuclear factor IB [67].
Since we did not see strong effects on MITF gene
expression in all cell lines tested, we do not assume
MITF to play a leading part in the observed effects. TYR
was additionally identified as a direct target of LEF1
dependent gene transcription [68].
The question arose, if the physiological neural crest
migration of melanoma cells was equal to malignant
invasive migration, as encountered in advanced melan-
oma patients, and if such malignant invasion was also
accessible for pharmacological manipulation through
inhibition of endogenous Wnt-signaling. Thus, we injected
untreated or PKF115–584 pre-conditioned human melan-
oma cells in the rhombencephalon of the chick embryo
and analyzed malignant invasion after 4 days. As expected,
the untreated melanoma cells formed tumor nodules in
the roof plate and adjacent mesenchyme, with single cells
and streets of cells invading the chick host tissues and
blood vessels. Interestingly, only actively invading melan-
oma cells with a mesenchymal morphology had a promin-
ent cytoplasmic β-catenin expression, and not the cells in
the tumor nodule displaying a compact, epithelial-like
morphology. This was in line with melanoma cells in pri-
mary melanomas displaying a high cytoplasmic β-catenin
expression at the invasive front. To our surprise, the
PKF115–584 pre-conditioned melanoma cells had under-
gone apoptosis, and in none of the embryos of this cohort
a viable tumor nodule could be detected. This is particu-
larly interesting since 48 h after injection into the neural
tube, even PKF115–584 pre-conditioned melanoma cells
were still positive for the proliferation marker MIB1,
and suggests that inhibition of Wnt-signaling with
PKF115–584 might lead to both complete inhibition
of neural crest migration and invasion (after 48 h) and to
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a delayed induction of cell death (up to 96 h). This is in
line with previous reports showing both anti-proliferative
and anti-invasive effects of β-catenin-inhibition in melan-
oma cells [16, 17, 30].
Conclusions
Together, our results show a novel role of Wnt3a/β-
catenin signaling in melanoma cell neural crest like
migration and invasion and suggest the participation
of β-catenin during active melanoma cell invasion
into the dermal matrix, the brain microcompartment
and during metastasis to the liver. The crucial role of
the embryonic neural crest signaling for melanoma
progression is underlined by a neural crest related
gene signature. Since non-canonical Wnt signaling
pathways that frequently involve Wnt5a are comple-
mentary strong contributors to the invasive behavior
of melanoma cells, we believe in a context dependent,
plastic effect of distinct Wnt ligands and their corre-
sponding receptorsor adaptors. We therefore suggest that
the malignant, invasive growth of melanoma cells could
be inhibited by novel inhibitors of Wnt secretion as
an additional therapeutic approach that might pre-
vent metastasis in melanoma patients.
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